Articles for category: Small Caps

March 31, 2025

Ron Finklestien

Innocan Pharma Achieves Record Revenues of US $29.4 Million in Full Year 2024, Doubling Previous Figures

Innocan Pharma Reports Impressive Financial Growth for 2024 HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /CNW/ — Innocan Pharma Corporation INNO IP INNPF (the “Company” or “Innocan“), a pharmaceutical technology firm focused on innovative drug delivery systems, announces its audited consolidated financial results for the year ended December 31, 2024. Financial Highlights for 2024 Revenues surged 114.6% year-over-year to US$29.4 million, rising from US$13.7 million in 2023. This growth was significantly driven by sales from Innocan’s subsidiary, BI Sky Global Ltd. Gross Profit climbed 118.6% year-over-year to US$26.2 million, compared to US$12.0 million in 2023. Operating Loss decreased by

March 30, 2025

Ron Finklestien

Else Nutrition Announces New Date for 2024 Fiscal Year Business Update Call

Else Nutrition Holdings Inc. Adjusts Business Update Conference Call Date VANCOUVER, BC, March 30, 2025 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. BABY BABYF 0YL (“Else” or the “Company”), has announced a change regarding its business update conference call. Originally planned for 10:00 a.m. Eastern Time on March 31, 2025, this call will be rescheduled, with the new date and time to be communicated in a subsequent news release. About Else Nutrition Holdings Inc. Else Nutrition Holdings Inc. BABYBABYF0YL is a food and nutrition company focused on international expansion. The company’s mission revolves around creating innovative, clean, and plant-based nutrition products

March 29, 2025

Ron Finklestien

WELL Health Postpones Annual Financial Statement Filing Amid Issues with US Subsidiary Circle Medical

WELL Health Technologies Delays Annual Financial Filings Amid Subsidiary Issues VANCOUVER, BC, March 28, 2025 /PRNewswire/ – WELL Health Technologies Corp. WELL WHTCF (“WELL” or the “Company“), a digital healthcare firm dedicated to improving health outcomes through technology, has announced a delay in filing its audited annual consolidated financial statements for the year ending December 31, 2024. This delay, which affects the mandatory management discussion and analysis as well as the CEO and CFO certificates (collectively, the “Required Filings“), pushes beyond the March 31, 2025 deadline (the “Deadline“). The delay arises from accounting issues related to the Company’s non-wholly owned

March 28, 2025

Ron Finklestien

“Investor Alert: Glancy Prongay & Murray LLP Initiates Class Action for Solaris Energy Infrastructure, Inc. Securities Fraud”

Class Action Filed Against Solaris Energy Over Misleading Claims Glancy Prongay & Murray LLP (“GPM”) has filed a class action lawsuit in the United States District Court for the Southern District of Texas, titled Pirello v. Solaris Energy Infrastructure, Inc., et al., Case No. 25-cv-01455. This case is on behalf of individuals and entities who purchased or acquired Solaris Energy Infrastructure, Inc. (“Solaris” or the “Company”) SEI securities between July 9, 2024, and March 17, 2025 (the “Class Period”). The plaintiff’s claims are made under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”). Investors

March 28, 2025

Ron Finklestien

Amendment Announcement for Press Release Regarding Offering Closure

Outcrop Silver Corrects Information on Recent Public Offering /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, March 27, 2025 /CNW/ – Outcrop Silver & Gold Corporation OCG OCGSF MRG (“Outcrop Silver” or the “Company“) has issued a correction regarding its previous press release dated March 27, 2025. The report initially stated that each unit in the public offering included one common share and one whole common share purchase warrant. The accurate structure is that each unit contains one common share and half of one common share purchase warrant. All other details concerning the

March 27, 2025

Ron Finklestien

HydrogenPro Secures $2.5 Million Purchase Order

HydrogenPro Secures $2.5 Million Order for Electrolyzers OSLO, Norway, March 27, 2025 /PRNewswire/ — HydrogenPro HYPRO has announced a purchase order for its high-pressure alkaline electrolyzers, valued at USD 2.5 million, from an undisclosed customer. Manufacturing of these electrolyzers is set to begin in early May 2025. Contact Information CONTACT: Martin Thanem Holtet, CFO+47 922 44 [email protected] Additional Information This information has been provided by Cision. For further details, visit: Cision News Release View original content:Press Release SOURCE HydrogenPro ASA © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

March 26, 2025

Ron Finklestien

Jane Healy Joins Photocure as Vice President and General Manager for EMEA Region

Photocure ASA Appoints Jane Healy as EMEA Vice President OSLO, Norway, March 26, 2025 /PRNewswire/ — Photocure ASA PHO, known as the Bladder Cancer Company, has appointed Jane Healy as Vice President and General Manager for EMEA. Ms. Healy’s Extensive Experience in the Medical Device Sector Joining Photocure in March 2025, Ms. Healy will lead the European organization. Her background spans over 30 years in the medical device industry, with significant roles in sales, marketing, general management, and functional leadership. She has previously held key positions at St Jude Medical, CR Bard, and Boston Scientific. Most recently, Jane Healy served

March 25, 2025

Ron Finklestien

KITS Eyecare Introduces Smooth Vision Care Insurance Integration for American Customers

67% of U.S. Adults Now Have Vision Care Coverage U.S. Eligibility Verification for All Major National Vision Plans VANCOUVER, BC , March 25, 2025 /PRNewswire/ – Kits Eyecare Ltd. KITS (“KITS” or the “Company”), a leading vertically integrated eyecare provider, has launched integrated vision care insurance support for customers in the United States. This new functionality allows for eligibility and benefits verification across all major U.S. vision insurance providers, enabling millions of Americans to swiftly and easily file claims electronically. Recent data reveals that 67% of adults in the U.S., which translates to over 174 million people, possess some form

March 24, 2025

Ron Finklestien

Regency Affiliates Declares Latest Quarterly Dividend

Regency Affiliates Announces Quarterly Dividend Increase to 7.8 Cents NEW YORK, March 24, 2025 /PRNewswire/ — Regency Affiliates, Inc. RAFI (“Regency”) has announced a quarterly dividend payment of 7.8 cents per common share. This payment is scheduled for April 7, 2025, to shareholders who hold shares at the close of trading on March 31, 2025. Management’s Commentary on Dividend and Performance Chairman, CEO, and CFO Laurence Levy remarked, “We are pleased to declare a quarterly dividend of 7.8 cents per common share, reflecting a 4% increase from the dividend paid in April 2024. We remain confident in maintaining this dividend

March 23, 2025

Ron Finklestien

Sabio Secures Funding Through Award Grant Initiative

Sabio Holdings Grants Stock Options to Directors and Employees TORONTO, March 21, 2025 /CNW/ — Sabio Holdings Inc. SBIO SABOF (the “Company” or “Sabio“), a Los Angeles-based ad-tech company focused on helping top brands engage and validate (R.E.V.) ad-supported streaming audiences, has announced the grant of 642,456 stock options (“Options”). These options are part of the Company’s Omnibus Equity Incentive Plan (“Plan”), allowing certain directors, officers, employees, and a consultant to acquire an aggregate of 642,456 common shares in the Company (“Shares”). The Options were granted effective March 21, 2025 (“Grant Date”) at an exercise price of CAD$0.62. They will